Back to TSHA

B Group, Inc. → TSHA

B Group, Inc. TSHA Position History

Taysha Gene Therapies, Inc. • Healthcare

Quarters held
4
Latest value
$8.8M
Q3 2026
Peak value
$12.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$9.9M
Q1 2026$8M
Q2 2026$12.3M
Q3 2026$8.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$8.8M1.80M——
Q2 2026$12.3M1.80M——
Q1 2026$8M1.80M——
Q4 2025$9.9M1.80M——

Other funds holding TSHA

Other B Group, Inc. positions

ADMA

ADMA BIOLOGICS INC

$44.8M
ADMA

ADMA BIOLOGICS INC

$32.7M
ADMA

ADMA BIOLOGICS INC

$28.9M
ADMA

ADMA BIOLOGICS INC

$27.3M
FTH

FAETH THERAPEUTICS INC

$18.1M
CLLS

CELLECTIS S A

$15.9M
FTH

FAETH THERAPEUTICS INC

$15.3M
ZLAB

ZAI LAB LTD

$11.9M